| 摘要: |
| 目的 对中成药说明书或外包装中“运动员慎用”标注情况进行分析,为运动员安全、合理使用中成药提供参考,为含兴奋剂中成药管理提供建议。方法 收集整理某院在用所有中成药说明书及外包装,依据《2024兴奋剂目录》筛选出含兴奋剂成分中成药,并运用对比分析法比较在“运动员慎用”方面标注的差异。结果 共收集到428种中成药说明书及其外包装,其中含兴奋剂成分中成药86种,仅44种说明书或外包装中标注“运动员慎用”,剩余42种未标注,未标注品种所含兴奋剂成分多为去甲乌药碱;未涉及标注但不含有兴奋剂成分情况。结论 应进一步完善中成药“运动员慎用”标注信息,避免运动员医源性误服。同时,建议药品监管部门联合体育总局等部门,加强对含兴奋剂成分中成药管理,进一步规范含兴奋剂中成药临床使用。 |
| 关键词: 中成药 说明书 兴奋剂 运动员慎用 |
| DOI:10.13506/j.cnki.jpr.2025.12.015 |
| 基金项目:山东省药物政策研究重点课题(No.YZY202407);齐鲁卫生与健康领军人才项目(No.2019);山东省中医药科技重点项目(No.Z-2023052);山东省药品临床综合评价项目(No.2022YZ003);山东中医药学会临床药学科研专项基金项目(No.SDACM202204);2023年度山东药品化妆品监测哨点课题(No.2023SDADRKY47) |
|
出版日期:2025-12-25
|
|
| Investigation and analysis of the labeling of "athletes use with caution" of 428 Chinese patent medicine in hospital |
| REN Yiwen1,LIU Qun2,LIU Xiaoqian2,XIN Yizhou2,DAI Yanpeng3 |
| (1.Shandong University of Traditional Chinese Medicine,Jinan 250355,China; 2.Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan 250011,China;3.Shandong Academy of Chinese Medicine,Jinan 250014,China) |
| Abstract: |
| Objective To analyze the specific situation of "Athletes use with caution" in the instructions or outer packaging of Chinese patent medicine(CPM), to provide reference for the safe and rational use of CPM by athletes, and to provide suggestions for the management of CPM containing stimulants.Methods All the instructions or outer packaging of CPM in use in a hospital were collected and sorted out, the CPM containing doping ingredients were screened according to the "2024 Doping Catalogue", and the differences compared by Comparative analysis method in the labeling of "Athletes use with caution".Results A total of 428 kinds of traditional Chinese patent medicines and simple preparations were collected, including 86 kinds of traditional Chinese patent medicines and simple preparations containing stimulant ingredients. Only 44 kinds of instructions or packages were marked with "athletes use with caution", and the remaining 42 kinds were not marked. Most of the stimulant ingredients contained in the unmarked varieties were higenamine. No labelling but no stimulant content is involved.Conclusion The labeling information or outer packaging of "Athletes use with caution" should be further improved to avoid iatrogenic misuse. At the same time, it is suggested that the drug regulatory department, together with the General Administration of Sports and other departments, strengthen the management of CPM containing stimulants and further regulate the clinical use of CPM containing stimulants. |
| Key words: Chinese patent medicine Instructions Stimulant Athletes use with caution |